The HIF1α transcriptional signature (46 samples) was enriched in tumors expressing high HIF1α levels....However, clusters were not associated with ORR (p=0.7455) or PFS (p=0.6058) in patients receiving pazopanib....the HIF1α gene expression signature was not associated with clinical outcome to pazopanib.